Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

International Immunology

Volumn 16, Issue 11, 2004, Pages 1643-4656

  Yagi, Haruhiko ^a,b   Nomura, Takashi ^a   Nakamura, Kyoko ^a   Yamazaki, Sayuri ^a   Kitawaki, Toshio ^b   Hori, Shohei ^c   Maeda, Michiyuki ^b   Onodera, Masafumi ^d   Uchiyama, Takashi ^b   Fujii, Shingo ^b   Sakaguchi, Shimon ^a,c,e  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autoimmunity; Immune regulation; Immunological tolerance; Transcription factor

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNE DISEASE; CELL INTERACTION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATORY DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL LINE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; RETROVIRUS; T LYMPHOCYTE; UPREGULATION;

AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; IMMUNE TOLERANCE; RECEPTORS, INTERLEUKIN-2; TRANSDUCTION, GENETIC;

EID: 8344275995     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh165     Document Type: Article

References (56)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
2. Maloy, K. J. and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
3. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
4. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.
5. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
6. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295.
7. + T cells with regulatory properties from human blood. J. Exp Med. 193:1303.
8. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122.
9. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247.
10. + human thymocytes. J. Exp. Med. 196:379.
11. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285.
12. + regulatory T cells. Eur. J. Immunol. 32:1621.
13. +high regulatory T cell function. J. Immunol. 169:6210.
14. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. and Ziegler, S. F. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:37672.
15. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A. et al. 2001. Disruption of a new forkhead/winged-helix protein, Scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68.
16. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
17. + regulatory T cells. Nat. Immunol. 4:330.
18. + T regulatory cells. Nat. Immunol. 4:337.
19. Chatila, T. A., Blaeser, F., Ho, N. et al. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Investig. 106:R75.
20. Wildin, R. S., Ramsdell, F., Peake, J. et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18.
21. Bennett, C. L., Christie, J., Ramsdell, F. et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20.
22. Godfrey, V. L., Wilkinson, J. E., Rinchik, E. M. and Russell, L. B. 1991. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl. Acad. Sci. USA 88:5528.
23. - T cells are the effector cells in disease pathogenesis in the scurfy (sf mouse. J. Immunol. 153:3764.
24. Clark, L. B., Appleby, M. W., Brunkow, M. E., Wilkinson, J. E., Ziegler, S. F. and Ramsdell, F. 1999. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162:2546.
25. Zahorsky-Reeves, J. L. and Wilkinson, J. E. 2001. The murine mutation scurfy (sf) results in an antigen-dependent lymphoproliferative disease with altered T cell sensitivity. Eur. J. Immunol. 31:196.
26. Iwama, A., Osawa, M., Hirasawa, R. et al. 2002. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195:547.
27. Miller, A. D. and Chen, F. 1996. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70:5564.
28. - T cells. J. Clin. Investig. 112:1437.
29. Maeda, M., Shimizu, A., Ikuta, K. et al. 1985. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J. Exp. Med. 162:2169.
30. Takeda, S., Maeda, M., Morikawa, S. et al. 2004. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 109:559.
31. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415.
32. Miyoshi, I., Kubonishi, I., Yoshimoto, S. et al. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770.
33. Imada, K., Takaori-Kondo, A., Akagi, T. et al. 1995. Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo. Blood 86:2350.
34. + regulatory T cells ex-vivo. Blood 102:2180.
35. Yodoi, J. and Uchiyama, T. 1986. IL-2 receptor dysfunction and adult T-cell leukemia. Immunol. Rev. 92:135.
36. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16:1055.
37. Pollok, K. E., Hanenberg, H., Noblitt, T. W. et al. 1998. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72:4882.
38. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135.
39. + regulatory T cells. J. Exp. Med. 194:847.
40. Bennett, C. L., Brunkow, M. E., Ramsdell, F. et al. 2001. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA →AAUGAA) leads to the IPEX syndrome. Immunogenetics 53:435.
41. Bassuny, W. M., Ihara, K., Sasaki, Y. et al. 2003. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 55:149.
42. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
43. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12:1145.
44. + regulatory T cells: thymus or periphery. J. Clin. Investig. 112:1310.
45. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149.
46. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
47. pos T cells by human mature autologous dendritic cells. Eur. J. Immunol. 34:762.
48. Maeda, M., Arima, N., Daitoku, Y. et al. 1987. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 70:1407.
49. + regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 126:81.
50. Bunn, P. A., Jr, Schechter, G. P., Jaffe, E. et al. 1983. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 309:257.
51. Yoshida, M. and Seiki, M. 1987. Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes. Annu. Rev. Immunol. 5:541.
52. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335.
53. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med. 196:247.
54. + T helper cells. J. Exp. Med. 196:255.
55. + regulatory T cells. J. Immunol. 172:5986.
56. Singh, B., Read, S., Asseman, C. et al. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190.